Breast cancer patients in "zero period" need no chemotherapy

Breast cancer is common malignancy of women worldwide each year about 50 million people died of breast cancer. In recent years, the incidence of breast cancer has also been ranked first in women, breast cancer treatment currently available drugs for broad classification of light has already reached more than 30 kinds. Faced with these drugs, patients should be how to choose? This issue, the reporter interviewed the millions of women breast screening project in China, Guangdong Province, chief expert, chairman of the Guangzhou Committee of Breast Cancer, Breast Surgery, Second Affiliated Hospital of Sun Yat-sen Professor Su Fengxi.

Western medicine treatment of choice for breast cancer

Many Chinese are also available in the market for cancer drugs into the market, Professor Su Fengxi personal emphasis: breast cancer, the preferred Western medicine. "This is because the incidence of breast cancer with the highest rates of Europe and the United States, the longest history of western medicine on breast cancer is also the longest time, experienced and well-developed human and material resources, the exact effects of western medicine." He believes that Chinese medicine in the treatment of breast cancer, may be effective, but not yet been recognized, this is because so far, no evidence of a purely evidence-based medicine as a treatment for breast cancer medicine to the main drug. "But this is not to say there is no medicine with Chinese herbal medicine, like chemotherapy drug paclitaxel in the extract is derived from the yew years, but the medicine has not come out of these drugs." He said.

8 steps to self-breast cancer expert advice

 

Are three major types of breast cancer drugs

Professor Su Fengxi told reporters that the current drug treatment of breast cancer consists of chemotherapy, endocrine therapy, biological therapy of three. "One of chemotherapeutic drugs CMF, anthracycline and paclitaxel three categories; endocrine drugs there are estrogen receptor antagonists and aromatase inhibitors; biological treatment called targeted therapy is the use of the new century began therapy. "

He said the drug treatment of breast cancer patients at different stages should be based on the situation. Early breast cancer surgery first, it is necessary procedures; second step is to meet the indications for chemotherapy patients, most patients go through; The third step is radiation therapy, some patients need; The fourth step is to endocrine therapy, a large Some patients need; fifth step is biological treatment, some patients need.

"Therapeutic use also has certain procedures. Illness younger patients, medication on the use of traditional medicines; patients with severe illness, medication may need to be available late in the drug. Different stages of the disease with different drugs, the higher degree of risk of recurrence, diagnosis and treatment of the later drug costs more expensive. "He explained that the clinical point of view, the later advent of drug efficacy is indeed stronger.

In addition, the drug treatment of breast cancer will be divided into first, second and third line, the preferred first-line advanced breast cancer drug, is invalid and eventually enable the second and third line drugs. "Sufeng Xi pointed out that the first-line drugs and which drugs are no clear boundaries, the need to judge patients with early drug use. In general, the greater the side effects, and more on the back, which means third-line drugs." Physicians should not start give breast cancer patients with a 'strong medicine', or back may be 'no cure'. "

"Zero of cancer," patients need chemotherapy

Su Fengxi said that if a "zero of cancer" (can not feel lumps, not developed to the catheter outside the breast cancer) patients, and can be omitted this part of chemotherapy, but many still receiving endocrine treatment. "Should patients with breast cancer endocrine therapy depends on her estrogen and progesterone receptors are positive. Once the medication generally have 5 to 10 years to maintain medication time." And after stopping six months to a close to the hospital during the year to review, because at this most vulnerable to relapse. Su Fengxi introduction, biological treatment must reach a certain drug targets patients to use, not everyone is suitable.